Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2025-08-18 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
DIRECTOR/PDMR SHAREHOLDING
Foreign Filer Report
2025-08-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification of a share transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically the Chief Financial Officer of AstraZeneca PLC. It details the sale of ordinary shares, including the price, volume, and date of the transaction, in compliance with the EU Market Abuse Regulation. This falls directly under the definition of 'Director's Dealing' (DIRS).
2025-08-18 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2025-08-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by AstraZeneca PLC. It explicitly details the acquisition of voting rights by The Capital Group Companies, Inc., crossing the 5% threshold. This fits the definition of a Major Shareholding Notification (MRQ), which tracks changes in significant share ownership levels.
2025-08-15 English
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 1% confidence The document is a formal notification of a change in major shareholding (flaggningsmeddelande) for AstraZeneca PLC, filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details the transaction date, the entity involved (The Capital Group Companies, Inc.), and the resulting percentage of voting rights and shares held (crossing the 5% threshold). This aligns perfectly with the definition of a Major Shareholding Notification.
2025-08-15 Swedish
HOLDING(S) IN COMPANY
Foreign Filer Report
2025-08-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.